Novel therapeutic approaches for heart failure by normalizing calcium cycling.
Wehrens
Xander H T
XH
Department of Physiology and Cellular Biophysics, Center for Molecular Cardiology, Columbia University College of Physicians and Surgeons, 630W 168th Street, P&S 9-401, New York, New York 10032, USA.
Marks
Andrew R
AR
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D020013:Calcium Signaling / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism*; D019837:Ryanodine Receptor Calcium Release Channel / Q000378:metabolism*; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D013841:Thiazepines / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D019837:Ryanodine Receptor Calcium Release Channel; D013841:Thiazepines; C109183:K201 compound; D002118:Calcium